H. Ralph Snodgrass - Net Worth and Insider Trading
H. Ralph Snodgrass Net Worth
The estimated net worth of H. Ralph Snodgrass is at least $9,265 dollars as of 2024-11-13. H. Ralph Snodgrass is the PRES./CHIEF SCIENTIFIC OFFICER of Vistagen Therapeutics Inc and owns about 3,162 shares of Vistagen Therapeutics Inc (VTGN) stock worth over $9,265. Details can be seen in H. Ralph Snodgrass's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that H. Ralph Snodgrass has not made any transactions after 2021-08-17 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.
Transaction Summary of H. Ralph Snodgrass
H. Ralph Snodgrass Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, H. Ralph Snodgrass owns 1 companies in total, including Vistagen Therapeutics Inc (VTGN) .
Click here to see the complete history of H. Ralph Snodgrass’s form 4 insider trades.
Insider Ownership Summary of H. Ralph Snodgrass
| Ticker | Comapny | Transaction Date | Type of Owner |
|---|---|---|---|
| VTGN | Vistagen Therapeutics Inc | 2021-08-17 | PRES./CHIEF SCIENTIFIC OFFICER |
H. Ralph Snodgrass Latest Holdings Summary
H. Ralph Snodgrass currently owns a total of 1 stock. H. Ralph Snodgrass owns 3,162 shares of Vistagen Therapeutics Inc (VTGN) as of August 17, 2021, with a value of $9,265.
Latest Holdings of H. Ralph Snodgrass
| Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| VTGN | Vistagen Therapeutics Inc | 2021-08-17 | 3,162 | 2.93 | 9,265 |
Holding Weightings of H. Ralph Snodgrass
H. Ralph Snodgrass Form 4 Trading Tracker
According to the SEC Form 4 filings, H. Ralph Snodgrass has made a total of 2 transactions in Vistagen Therapeutics Inc (VTGN) over the past 5 years, including 2 buys and 0 sells. The most-recent trade in Vistagen Therapeutics Inc is the acquisition of 125 shares on August 17, 2021, which cost H. Ralph Snodgrass around $10,238.
Insider Trading History of H. Ralph Snodgrass
- 1
H. Ralph Snodgrass Trading Performance
GuruFocus tracks the stock performance after each of H. Ralph Snodgrass's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by H. Ralph Snodgrass is 42.06%. GuruFocus also compares H. Ralph Snodgrass's trading performance to market benchmark return within the same time period. The performance of stocks bought by H. Ralph Snodgrass within 3 months outperforms 1 times out of 2 transactions in total compared to the return of S&P 500 within the same period.
You can select different timeframes to see how H. Ralph Snodgrass's insider trading performs compared to the benchmark.
Performance of H. Ralph Snodgrass
Average Return
Outperforming Transactions
| 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | 3 Years | |
|---|---|---|---|---|---|---|
| Return(%) | 76.79 | | | | | |
| Relative Return to S&P 500(%) | 75.14 | | | | | |
H. Ralph Snodgrass Ownership Network
Ownership Network List of H. Ralph Snodgrass
Ownership Network Relation of H. Ralph Snodgrass
H. Ralph Snodgrass Owned Company Details
What does Vistagen Therapeutics Inc do?
Who are the key executives at Vistagen Therapeutics Inc?
H. Ralph Snodgrass is the PRES./CHIEF SCIENTIFIC OFFICER of Vistagen Therapeutics Inc. Other key executives at Vistagen Therapeutics Inc include Chief Operating Officer Joshua S. Prince , CHIEF FINANCIAL OFFICER Cynthia Lynn Anderson , and 10 percent owner Commodore Capital Lp .
Vistagen Therapeutics Inc (VTGN) Insider Trades Summary
Over the past 18 months, H. Ralph Snodgrass made no insider transaction in Vistagen Therapeutics Inc (VTGN). Other recent insider transactions involving Vistagen Therapeutics Inc (VTGN) include a net purchase of 775,756 shares made by Commodore Capital Lp ,
In summary, during the past 3 months, insiders sold 0 shares of Vistagen Therapeutics Inc (VTGN) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Vistagen Therapeutics Inc (VTGN) were sold and 775,756 shares were bought by its insiders, resulting in a net purchase of 775,756 shares.
Vistagen Therapeutics Inc (VTGN)'s detailed insider trading history can be found in Insider Trading Tracker table.
Vistagen Therapeutics Inc Insider Transactions
H. Ralph Snodgrass Mailing Address
Above is the net worth, insider trading, and ownership report for H. Ralph Snodgrass. You might contact H. Ralph Snodgrass via mailing address: 384 Oyster Point Blvd. Suite 8, South San Francisco Ca 94080.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
